BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 24899689)

  • 21. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
    Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
    Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
    J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SIRT3 Blocks Aging-Associated Tissue Fibrosis in Mice by Deacetylating and Activating Glycogen Synthase Kinase 3β.
    Sundaresan NR; Bindu S; Pillai VB; Samant S; Pan Y; Huang JY; Gupta M; Nagalingam RS; Wolfgeher D; Verdin E; Gupta MP
    Mol Cell Biol; 2015 Dec; 36(5):678-92. PubMed ID: 26667039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
    Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
    Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
    Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
    J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2,5-Dimethylcelecoxib attenuates cardiac fibrosis caused by cryoinjury-induced myocardial infarction by suppressing the fibroblast-to-myofibroblast transformation via inhibition of the TGF-β signaling pathway.
    Ikushima E; Ishikane S; Kishigami T; Matsunaga H; Igawa K; Tomooka K; Nishimura Y; Takahashi-Yanaga F
    Biochem Pharmacol; 2022 Mar; 197():114950. PubMed ID: 35143754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
    J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts.
    Caraci F; Gili E; Calafiore M; Failla M; La Rosa C; Crimi N; Sortino MA; Nicoletti F; Copani A; Vancheri C
    Pharmacol Res; 2008 Apr; 57(4):274-82. PubMed ID: 18346908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotinamide riboside kinase-2 alleviates ischemia-induced heart failure through P38 signaling.
    Ahmad F; Tomar D; Aryal A C S; Elmoselhi AB; Thomas M; Elrod JW; Tilley DG; Force T
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165609. PubMed ID: 31743747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure.
    Ahmad F; Lal H; Zhou J; Vagnozzi RJ; Yu JE; Shang X; Woodgett JR; Gao E; Force T
    J Am Coll Cardiol; 2014 Aug; 64(7):696-706. PubMed ID: 25125302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway.
    Bergmann C; Akhmetshina A; Dees C; Palumbo K; Zerr P; Beyer C; Zwerina J; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2011 Dec; 70(12):2191-8. PubMed ID: 21873331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pressure overload regulates expression of cytokines, γH2AX, and growth arrest- and DNA-damage inducible protein 153 via glycogen synthase kinase-3β in ischemic-reperfused hearts.
    Baban B; Liu JY; Mozaffari MS
    Hypertension; 2013 Jan; 61(1):95-104. PubMed ID: 23108649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ectonucleoside triphosphate diphosphohydrolase-1 (CD39) impacts TGF-β1 responses: insights into cardiac fibrosis and function following myocardial infarction.
    Novitskaya T; Nishat S; Covarrubias R; Wheeler DG; Chepurko E; Bermeo-Blanco O; Xu Z; Baer B; He H; Moore SN; Dwyer KM; Cowan PJ; Su YR; Absi TS; Schoenecker J; Bellan LM; Koch WJ; Bansal S; Feoktistov I; Robson SC; Gao E; Gumina RJ
    Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1244-H1261. PubMed ID: 36240436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
    Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
    Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling.
    Wang Y; Feng W; Xue W; Tan Y; Hein DW; Li XK; Cai L
    Diabetes; 2009 Jun; 58(6):1391-402. PubMed ID: 19324938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local delivery of PKCepsilon-activating peptide mimics ischemic preconditioning in aged hearts through GSK-3beta but not F1-ATPase inactivation.
    Korzick DH; Kostyak JC; Hunter JC; Saupe KW
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2056-63. PubMed ID: 17675573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis.
    Guo Y; Gupte M; Umbarkar P; Singh AP; Sui JY; Force T; Lal H
    J Mol Cell Cardiol; 2017 Sep; 110():109-120. PubMed ID: 28756206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
    Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
    Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B; Johnson JN; Ross RS; Singh M; Singh K
    J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
    Daniel LL; Scofield SL; Thrasher P; Dalal S; Daniels CR; Foster CR; Singh M; Singh K
    Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H445-52. PubMed ID: 27288435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.